Changes of Antibody Associated with Cell-Mediated Immunity in College Students During Two Years after Rubella Vaccination
Journal Title: UNKNOWN - Year 2017, Vol 8, Issue 6
Abstract
Objective: This study measured cell-mediated immunity (CMI) and serum antibody levels against rubella to clarify antibody changes associated with CMI during 2 years after vaccination. Methods: The study subjects were 64 college students in two groups: 38 subjects who (having exhibited hemagglutination-inhibition (HI) anti-rubella antibody titers of ≤ 1:16) had been vaccinated with a rubella vaccine 2 years previously (Group 1); and 26 subjects who (having exhibited HI titers ≥ 1:32) had not been vaccinated 2 years previously (Group 2). All students were tested for IgG antibody levels (by enzyme-linked immunosorbent assay) and CMI (by interferon-γ (IFN-γ release assay). Results: The IgG antibody and IFN-γ values decreased significantly in Group 1 during the 2 years postvaccination, while antibody titers in Group 2 did not decrease over this interval. The proportion of Group-1 individuals with HI antibody titers ≤ 1:16 increased to 27/38 (71.1%) at two years following vaccination, compared with 6/26 (23.1%) in Group 2. No correlation of IgG antibody titers was observed in Group 1 between one month and two years after vaccination. However, a strong correlation (r=0.85, p<0.00001) was detected in Group 2 between two years ago and the present. The correlation of IFN-γ values in Group 1 between one month and two years after vaccination was 0.614 (p<0.00005). When the subjects were classified by CMI status, the numbers of individuals who were intermediate and negative for IgG antibody at two years after vaccination were 1 and 0 of 13 subjects, 3 and 1 of 9 subjects, and 3 and 2 of 16 subjects in Group 1, respectively, while the antibody-positive status was maintained in all subjects in Group 2. Conclusion: The IgG antibody and IFN-γ values decreased in distinct ways during the 2 years of the study; the persistence of the seropositivity was associated with CMI status.
Authors and Affiliations
Kihei Terada, Kimiko Hagihara, Yuhei Tanaka, Hideto Teranishi, Tomohiro Oishi,, Ippei Miyata, Satoko Ogita,, Kazunobu Ouchi, Naoki Ohno
Novel Heat-Stable Enterotoxin (STa) Immunogen Based on Cationic Nanoliposomes: Preparation, Characterization and Immunization
The novelties encountered in the field of formulation have provided promising solutions for the problematic vaccine development of hapten molecules. In the current study, the novel preparation of a cationic nanoliposomal...
Development of an in vitro Biochemical Assay System for the Measurement of Residual Toxin Activities in Pertussis Toxin Containing Vaccines
Pertussis (whooping cough) vaccines play an essential role in immunisation programmes worldwide and the histamine sensitisation test (HIST) is currently the official batch-release test for acellular pertussis containing...
Immune Response Modifying Effects of Bee Venom Protein [Melittin]/Autoclaved L. donovani complex in CD1 Mice: The Search for New Vaccine Adjuvants
Visceral leishmaniasis (VL) is a major cause of morbidity/mortality in remote areas of East Africa. Vaccines for VL can provide an effective control measure to help control/eliminate this fatal disease. To date there is...
MEFA (multiepitope fusion antigen) - Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA
Vaccine development often encounters the challenge of virulence heterogeneity. Enterotoxigenic Escherichia coli (ETEC) bacteria producing immunologically heterogeneous virulence factors are a leading cause of children’s...
Emergence of Antibiotic Resistance in Pakistan; A Clear Problem for Future
The capacity of bacteria to resist against the effects of an antibiotic is called antibiotic resistance. Antibiotic resistance is due to the change in bacteria by some approach that eliminates or reduces the efficiency o...